Omar S Aljitawi
Overview
Explore the profile of Omar S Aljitawi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
860
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mina A, Shune L, Abdelhakim H, Lin T, Ganguly S, Baran A, et al.
Ann Hematol
. 2018 Nov;
98(2):481-489.
PMID: 30382305
Umbilical cord blood (UCB) transplantation is a promising option for hematopoietic stem cell transplantation in patients with hematologic malignancies who lack an HLA-matched sibling or well-matched unrelated donor; however, it...
12.
Aljitawi O, Hari P
Int J Hematol Oncol
. 2018 Oct;
5(1):5-10.
PMID: 30302199
High-dose melphalan has been the drug of choice for preparative regimens for autologous stem cell transplantation in multiple myeloma. Propylene-free melphalan (Evomela™) is a newer formulation of melphalan, which incorporates...
13.
Li D, Lin T, Lipe B, Hopkins R, Shinogle H, Aljitawi O
Leuk Res
. 2018 Aug;
72:105-112.
PMID: 30130689
Acute myeloid leukemia (AML) relapse results from the survival of chemotherapy-resistant and quiescent leukemia stem cells (LSC). These LSCs reside in the bone marrow microenvironment, comprised of other cells and...
14.
15.
Cheung K, Berry A, Li D, Aljitawi O
Cytotherapy
. 2017 Oct;
20(1):87-94.
PMID: 29037940
Background Aims: Umbilical cord blood (UCB) provides an alternative source for hematopoietic stem/progenitor cells (HSPCs) in the treatment of hematological malignancies. However, clinical usage is limited due to the low...
16.
Converse G, Li D, Buse E, Hopkins R, Aljitawi O
Methods Mol Biol
. 2017 Aug;
1577:25-33.
PMID: 28786033
Scaffolds, both natural and synthetic, used in tissue engineering provide mechanical support to cells. Tissue decellularization has been used to provide natural extracellular matrix scaffolds for tissue engineering purposes. In...
17.
Aljitawi O, Laughlin M, Broxmeyer H
Expert Rev Hematol
. 2017 Jul;
10(8):675-677.
PMID: 28665231
No abstract available.
18.
Jadalannagari S, Converse G, McFall C, Buse E, Filla M, Villar M, et al.
PLoS One
. 2017 Feb;
12(2):e0172098.
PMID: 28222169
In tissue engineering, an ideal scaffold attracts and supports cells thus providing them with the necessary mechanical support and architecture as they reconstruct new tissue in vitro and in vivo....
19.
Aljitawi O, Paul S, Ganguly A, Lin T, Ganguly S, Vielhauer G, et al.
Blood
. 2016 Oct;
128(25):3000-3010.
PMID: 27760758
Umbilical cord blood (UCB) engraftment is in part limited by graft cell dose, generally one log less than that of bone marrow (BM)/peripheral blood (PB) cell grafts. Strategies toward increasing...
20.
Potential mechanisms underlying ectodermal differentiation of Wharton's jelly mesenchymal stem cells
Jadalannagari S, Berry A, Hopkins R, Bhavsar D, Aljitawi O
Biochem Biophys Res Commun
. 2016 Aug;
478(2):831-7.
PMID: 27501759
Wharton's jelly mesenchymal stem cells (WJMSCs) are being increasingly recognized for their ectodermal differentiation potential. Previously, we demonstrated that when WJMSC were seeded onto an acellular matrix material derived from...